171 related articles for article (PubMed ID: 38495113)
1. Myofibroblasts reside in the middle dermis of the keloids but do not predict the response to injection therapies: a double-blinded, randomized, controlled trial.
Komulainen T; Daymond P; Hietanen KE; Kaartinen IS; Järvinen TAH
Front Med (Lausanne); 2024; 11():1293028. PubMed ID: 38495113
[TBL] [Abstract][Full Text] [Related]
2. Histopathology and immunohistochemical analysis of 5-fluorouracil and triamcinolone treated keloids in double-blinded randomized controlled trial.
Hietanen KE; Järvinen TAH; Huhtala H; Tolonen TT; Kaartinen IS
Wound Repair Regen; 2020 May; 28(3):385-399. PubMed ID: 32112591
[TBL] [Abstract][Full Text] [Related]
3. Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections - a randomized controlled trial.
Hietanen KE; Järvinen TA; Huhtala H; Tolonen TT; Kuokkanen HO; Kaartinen IS
J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):4-11. PubMed ID: 30448246
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a triamcinolone acetonide-loaded dissolving microneedle patch for the treatment of hypertrophic scars and keloids: a randomized, double-blinded, placebo-controlled split-scar study.
Disphanurat W; Sivapornpan N; Srisantithum B; Leelawattanachai J
Arch Dermatol Res; 2023 May; 315(4):989-997. PubMed ID: 36383222
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: Randomised control trial.
Khalid FA; Mehrose MY; Saleem M; Yousaf MA; Mujahid AM; Rehman SU; Ahmad S; Tarar MN
Burns; 2019 Feb; 45(1):69-75. PubMed ID: 30340861
[TBL] [Abstract][Full Text] [Related]
6. Myofibroblasts Are Not Characteristic Features of Keloid Lesions.
Hahn JM; McFarland KL; Combs KA; Powell HM; Supp DM
Plast Reconstr Surg Glob Open; 2022 Nov; 10(11):e4680. PubMed ID: 36448015
[TBL] [Abstract][Full Text] [Related]
7. The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis.
Zhuang Z; Li Y; Wei X
Burns; 2021 Aug; 47(5):987-998. PubMed ID: 33814214
[TBL] [Abstract][Full Text] [Related]
8. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
Ogawa R
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
[TBL] [Abstract][Full Text] [Related]
9. Exclusive expression of KANK4 promotes myofibroblast mobility in keloid tissues.
Oishi M; Shinjo K; Takanari K; Muraoka A; Suzuki MM; Kanbe M; Higuchi S; Ebisawa K; Hashikawa K; Kamei Y; Kondo Y
Sci Rep; 2024 Apr; 14(1):8725. PubMed ID: 38622256
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Intralesional Triamcinolone Versus Combination of Triamcinolone with 5-Fluorouracil in the Treatment of Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis.
Jiang ZY; Liao XC; Liu MZ; Fu ZH; Min DH; Yu XT; Guo GH
Aesthetic Plast Surg; 2020 Oct; 44(5):1859-1868. PubMed ID: 32342167
[TBL] [Abstract][Full Text] [Related]
11. Strontium-90 brachytherapy following intralesional triamcinolone and 5-fluorouracil injections for keloid treatment: A randomized controlled trial.
Deng K; Xiao H; Liu X; Ogawa R; Xu X; Liu Y
PLoS One; 2021; 16(3):e0248799. PubMed ID: 33755674
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Small Keloids Using Intralesional 5-fluorouracil and Triamcinolone Acetonide versus Intralesional Bleomycin and Triamcinolone Acetonide.
Sharma S; Vinay K; Bassi R
J Clin Aesthet Dermatol; 2021 Mar; 14(3):17-21. PubMed ID: 33841611
[No Abstract] [Full Text] [Related]
13. Recurrence rates in the treatment of keloids and hypertrophic scars with intralesional triamcinolone combined with other intralesional agents.
Rimmer SN; Chandy RJ; Khan D; Feldman SR
Arch Dermatol Res; 2023 Dec; 315(10):2757-2767. PubMed ID: 37432467
[TBL] [Abstract][Full Text] [Related]
14. Equine exuberant granulation tissue and human keloids: a comparative histopathologic study.
Theoret CL; Olutoye OO; Parnell LK; Hicks J
Vet Surg; 2013 Oct; 42(7):783-9. PubMed ID: 24015864
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids.
Sadeghinia A; Sadeghinia S
Dermatol Surg; 2012 Jan; 38(1):104-9. PubMed ID: 22093096
[TBL] [Abstract][Full Text] [Related]
16. A one-time pneumatic jet-injection of 5-fluorouracil and triamcinolone acetonide for treatment of hypertrophic scars-A blinded randomized controlled trial.
Erlendsson AM; Rosenberg LK; Lerche CM; Togsverd-Bo K; Wiegell SR; Karmisholt K; Philipsen PA; Hansen ACN; Janfelt C; Holmes J; Rossi A; Haedersdal M
Lasers Surg Med; 2022 Jul; 54(5):663-671. PubMed ID: 35266202
[TBL] [Abstract][Full Text] [Related]
17. Laser therapy for treating hypertrophic and keloid scars.
Leszczynski R; da Silva CA; Pinto ACPN; Kuczynski U; da Silva EM
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD011642. PubMed ID: 36161591
[TBL] [Abstract][Full Text] [Related]
18. Keloid tissue analysis discredits a role for myofibroblasts in disease pathogenesis.
Bell RE; Shaw TJ
Wound Repair Regen; 2021 Jul; 29(4):637-641. PubMed ID: 33961308
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of excision followed by intralesional 5-fluorouracil and triamcinolone acetonide versus excision followed by radiotherapy in the treatment of ear keloids: A randomized control trial.
Khalid FA; Farooq UK; Saleem M; Rabbani J; Amin M; Khan KU; Mehrose Y; Tarar MN
Burns; 2018 Sep; 44(6):1489-1495. PubMed ID: 29534885
[TBL] [Abstract][Full Text] [Related]
20. Keloid Scars: An Updated Review of Combination Therapies.
Thornton NJ; Garcia BA; Hoyer P; Wilkerson MG
Cureus; 2021 Jan; 13(1):e12999. PubMed ID: 33542883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
